Evidence map›Paper›PMID 41555377›Full record

ReviewReproductive biology and endocrinology : RB&E2026

Mechanism and potential therapeutic strategies of genetic abnormalities involved in deoxyribonucleic acid double-strand breaks leading to the development of human non-obstructive azoospermia.

Xiaomei Wang, Yixin Zhang, Ziming Zhu, Caiqin Wang, Mengmeng Yao, Haohui Xu, Zhimin Zhang, Huiyu Ping, Xu Xia, Kai Meng and 2 more

Abstract readReview
In one paragraph

Review in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaomei Wang *College of Basic Medicine, Jining Medical University, Jining, China.
Yixin Zhang *Lin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Ziming ZhuLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Caiqin WangLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Mengmeng YaoLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Haohui XuLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Zhimin ZhangLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Huiyu PingLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Xu XiaLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China.
Kai MengLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China. mengkai521888@126.com.
Fei GaoLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China. gaof@ioz.ac.cn.
Jinxiang YuanLin He's Academician Workstation of New Medicine and Clinical Translation, Jining Medical University, Jining, China. yuanjinxiang18@163.com.

Funding

College Students' Innovation Training Program of Jining Medical University cx2024007zCollege Students' Innovation Training Program of Jining Medical University S202410443150Lin He's Academician Workstation of New Medicine and Clinical Translation in Jining Medical University JYHL2021MS10Lin He's Academician Workstation of New Medicine and Clinical Translation in Jining Medical University JYHL2021MS13the Research Start-up Fund of Jining Medical University 600791001the Research Start-up Fund of Jining Medical University 600980001
6 · The paper itself

Abstract

backgroundNon-obstructive azoospermia (NOA) is a testicular or pre-testicular spermatogenic disorder characterized by severe impairment in sperm production due to testicular dysfunction. Whole-exome sequencing has identified mutations in several genes related to double-strand break (DSB) formation and repair in patients with NOA. In this review, we aimed to comprehensively elucidate the relationship between DSB formation and repair-related gene abnormalities, and NOA occurrence.

methodsThis review summarizes current knowledge on the role of DSB-related gene mutations in NOA, focusing on their functions in meiotic recombination and deoxyribonucleic acid repair pathways.

resultsProgrammed formation of DSB is a key step in meiosis, initiating recombination and exchange between homologous chromosomes to ensure accurate transmission of genetic material. Under normal conditions, DSBs are generated during meiosis in spermatocytes, and their repair primarily involves homologous recombination, non-homologous end-joining, and single-strand annealing. Abnormalities in genes regulating DSB formation or repair disrupt meiosis, impair spermatogenesis, and induce the occurrence of NOA.

conclusionThis review highlights the association between DSB formation and repair gene abnormalities and the pathogenesis of NOA. In addition, we summarize the therapeutic potential of targeting DSB repair-related pathways, providing new insights into the mechanisms and treatment strategies for NOA.

Indexed as

AzoospermiaDNA Breaks, Double-StrandedDNA RepairHumansMaleMeiosisMutationSpermatogenesisDNA double-strand breakNon-obstructive azoospermiaTreatment

Identifiers

PMID41555377
PMCPMC12903559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.